Most dogs tolerate Cosequin without trouble, and the side effects that do show up are almost always digestive: soft stool, a skipped meal, an episode of vomiting in the first week. The ingredients involved — glucosamine hydrochloride, chondroitin sulfate, sometimes MSM and manganese — have a long safety record in dogs at label amounts. The genuinely serious problems documented in the veterinary literature involve massive accidental ingestion, not daily use, and they trace back to manganese rather than to glucosamine.
Quick answer: Reported side effects of Cosequin in dogs are mainly gastrointestinal — loose stool, vomiting, reduced appetite, gas — and they tend to appear early and resolve. Allergic-type reactions (facial swelling, hives, itching) are described but rare. The one well-documented severe scenario in the veterinary literature is acute liver failure after a dog eats a large quantity of joint supplement tablets at once, linked to manganese toxicosis rather than to glucosamine or chondroitin. Give the product with food, store the container where your dog can’t reach it, and call your veterinarian rather than adjusting the amount yourself.
For background on what the product is and how the different formulas differ, see our full guide to Cosequin for dogs.
What is actually in Cosequin, and why does that matter for side effects?
You can’t reason about side effects without knowing what’s in the tablet. Nutramax publishes the active ingredient panel on its own product pages. For Cosequin Chewable Tablets with MSM, the label states each chewable tablet contains glucosamine hydrochloride (FCHG49) 600 mg, sodium chondroitin sulfate (TRH122) 300 mg, methylsulfonylmethane (MSM) 250 mg, and manganese (as manganese ascorbate) 3 mg.
That fourth line is the one owners skip and the one that matters most in an overdose. Manganese is an essential trace mineral at small amounts and a hepatotoxin at large ones. Everything else on the panel has a wide margin of safety; manganese is the ingredient that turns a chewed-through bottle into an emergency.
The other formulas in the range vary — some add hyaluronic acid, omega-3s, or boswellia — so the panel on the bottle in your kitchen is the only one that describes your dog’s exposure. If you’re weighing one formula against another, how Dasuquin and Cosequin differ covers the ingredient-by-ingredient comparison.
What side effects are reported in dogs, and how strong is the evidence?
Here’s the honest picture, sorted by body system and by how much evidence actually stands behind each item. Nothing in this table is a diagnosis, and none of it predicts what your individual dog will do.
| Body system | What’s reported | Evidence strength | Notes |
|---|---|---|---|
| Gastrointestinal | Soft stool or diarrhea, vomiting, reduced appetite, flatulence | Moderate — consistently described clinically; controlled trials report adverse events as uncommon | Usually early and self-limiting; giving with food is standard advice |
| Immune / dermatologic | Itching, hives, facial swelling after dosing | Weak — case-level reports, no controlled canine data | Any facial swelling or breathing change is an urgent call, not a wait-and-see |
| Hepatic | Acute liver injury and failure | Strong, but only in published overdose case reports, attributed to manganese | Not a described consequence of label-amount daily use |
| Neurologic | Ataxia (wobbliness) alongside vomiting in acute overdose | Case report level, overdose only | Reported in the Borchers et al. (2014) case |
| Hematologic / clotting | Minor laboratory changes in short study periods; coagulopathy in severe overdose | Weak for routine use; case-level in overdose | Relevant if your dog is on anticoagulants or heading to surgery |
| Metabolic / glycemic | Theoretical concern about glucose handling because glucosamine is an amino sugar | Weak in dogs — a hypothesis, not an established canine effect | Worth mentioning to your vet if your dog is diabetic |
In the randomized, double-blind, positive-controlled trial by McCarthy and colleagues (The Veterinary Journal, 2007), 35 dogs with confirmed hip or elbow osteoarthritis received either a glucosamine hydrochloride/chondroitin sulfate combination or carprofen as a positive control. The glucosamine/chondroitin group showed statistically significant improvement in pain, weight-bearing and severity scores by day 70, with a slower onset than the carprofen group. Safety, not efficacy, is the point here: the trial ran ten weeks of daily dosing in client-owned dogs without a safety signal emerging as the story of the paper.
A later and less flattering trial is worth knowing about for the sake of expectation-setting. Kampa and colleagues (Frontiers in Veterinary Science, 2023) randomized 75 owned dogs with hip osteoarthritis across five groups including glucosamine/chondroitin, two marine fatty acid compounds, carprofen and placebo, using force-plate peak vertical force as the objective outcome. At four and six weeks, the marine compounds and carprofen improved significantly over placebo; the glucosamine/chondroitin group did not. Bhathal and colleagues, reviewing the canine literature in Open Veterinary Journal (2017), reached a similar verdict — evidence limited and conflicting, with a shortage of well-designed trials.
That combination — a benign side effect profile alongside genuinely mixed efficacy evidence — is the fair summary. The risk of trying it is low. The certainty of benefit is lower than the marketing suggests. If you want the wider evidence picture on the ingredient itself, what the research says about glucosamine for dogs goes deeper.
How dangerous is an accidental overdose?
This is the part of the topic that deserves more attention than it usually gets, because it’s where the documented harm lives.
ASPCA Pro’s toxicology guidance notes that oral chondroprotective agents have historically been considered to have wide safety margins, citing oral glucosamine LD50 figures in animals around 8,000 mg/kg with no adverse effects reported at 2,700 mg/kg over 12 months — figures from the toxicology literature, not dosing advice for you. Their guidance also flags the shift in thinking: a published case of hepatic failure after a joint supplement overdose, with severely elevated manganese in liver and kidney.
That case is Borchers and colleagues (Journal of Veterinary Diagnostic Investigation, 2014), from UC Davis. A 5-year-old spayed female Pug presented with vomiting and ataxia after eating approximately 100 joint supplement tablets, developed acute hepatic failure, and was euthanized six days after presentation; necropsy showed severe acute hepatic necrosis with severely elevated manganese in liver and kidney tissue.
Jaffey and colleagues (Topics in Companion Animal Medicine, 2024) described two dogs in the same household that ate roughly 75 capsules of a human joint supplement, with 2,062 mg of manganese ingested between them. One developed fulminant liver failure with coagulopathy and died within 36 to 48 hours. The second developed severe acute liver injury, was hospitalized for six days with supportive care, and had clinical and biochemical resolution by day 44.
Three dogs across those two reports, one mechanism. This is a small literature by design — Jaffey and colleagues note that before their own paper, the published veterinary record of acute manganese intoxication in dogs consisted of two reports covering three dogs. The practical lesson is unglamorous: a palatable chewable your dog likes is a food item to him, and the bottle belongs behind a closed door. If your dog gets into the container, this is an emergency call to your veterinarian or a pet poison control line — not a search-and-monitor situation.
When should you keep going, pause, or stop?
| Situation | Reasonable response |
|---|---|
| Slightly soft stool in the first few days, dog otherwise bright and eating | Keep going and mention it at your next appointment; ask your vet whether giving it with a meal helps |
| One episode of vomiting, then normal | Keep going, watch, and tell your vet if it repeats |
| Repeated vomiting, diarrhea lasting more than a day, or refusing food | Pause and call your veterinarian before the next dose |
| Itching, hives, or a rash that started after you began the product | Pause and call — describe the timing precisely |
| Facial or muzzle swelling, difficulty breathing, collapse | Stop and seek emergency veterinary care immediately |
| Yellow gums or eyes, dark urine, marked lethargy, unexplained bruising | Stop and seek veterinary care the same day |
| Your dog ate multiple doses or got into the bottle | Emergency call now, with the label in hand so the manganese content can be read out |
| No visible change after several weeks of consistent use | Not a side effect — a reason to revisit the whole plan with your vet |
This framework is about triage, not treatment. Any decision to change, pause or resume a supplement belongs to the veterinarian who can examine your dog.
When to call your vet
Call before you start if your dog is diabetic or has any known problem with glucose regulation, has existing liver or kidney disease, is on an anticoagulant or is scheduled for surgery, is pregnant or nursing, or is already taking another joint product — stacking two supplements can double an ingredient you never intended to double, manganese included.
Call during use for any reaction in the table above, for anything that starts within hours of a dose and repeats, or for a dog on long-term NSAIDs whose appetite or stool changes, since a supplement side effect and an NSAID side effect can look identical from the outside.
Call after any accidental ingestion of more than the labeled amount, with the bottle available so the active ingredient panel can be read verbatim.
A veterinary exam also separates “this supplement upset my dog” from “my dog’s arthritis is progressing and needs a different plan.” Those are different problems with different answers, and the second one is far more common than the first. Broader management options are covered in our overview of joint pain relief for dogs.
Myth vs fact
Myth: my dog is allergic to shellfish, so glucosamine is dangerous for him. The glucosamine used in these products is typically derived from crustacean shell chitin, and shellfish allergy in people is usually a reaction to muscle protein rather than to shell material. Gray and colleagues examined this question directly in humans (Journal of Allergy and Clinical Immunology, 2004) and the concern has generally not held up. Canine-specific data are thin, so raise it with your vet rather than assuming either way.
Myth: a bigger dose works faster. The label pattern Nutramax publishes actually runs the other direction — a higher number of tablets for an initial period, then a lower maintenance number after that. Follow your product label or your veterinarian, and never scale by eye.
Myth: side effects show up months in. The reported pattern is early and digestive. A new problem appearing after a year of uneventful use is more likely to be something else, and deserves a workup rather than an assumption.
Myth: “natural” means no interactions. Look at a related joint product with an FDA-approved label: Adequan Canine, an injectable polysulfated glycosaminoglycan, states on its label that PSGAG is a synthetic heparinoid and is not to be used in dogs with known or suspected bleeding disorders. That’s a different product class from an oral chewable, and none of it transfers directly to Cosequin — but it illustrates why “supplement” doesn’t mean “tell no one.”
Common mistakes owners make
Giving it on an empty stomach when the dog has a sensitive gut. Leaving a palatable chewable within reach. Running two joint products at once without adding up the shared ingredients. Starting a supplement and a new prescription in the same week, which makes any reaction impossible to attribute. Stopping after ten days because nothing happened — the McCarthy trial’s significant improvements were measured at day 70, not day 10. And treating a supplement as a substitute for a diagnosis, when weight management, controlled exercise and veterinary pain management carry far more evidence for arthritic dogs than any capsule does. Our guide to choosing a dog joint supplement walks through how to compare products without double-dosing.
Frequently asked questions
Can Cosequin cause diarrhea in dogs?
Loose stool is the most commonly described reaction, typically in the first days of use, and it usually resolves. Controlled trials report adverse events in dogs as uncommon overall. If diarrhea lasts more than a day or your dog is also vomiting or off food, pause and call your veterinarian.
Can Cosequin damage a dog’s liver?
Not at labeled amounts, based on published evidence. Acute liver failure has been documented in dogs after massive accidental ingestion of joint supplement tablets, and in those cases the liver injury was attributed to manganese toxicosis, with severely elevated manganese in liver and kidney tissue. Keep the container out of reach and treat any overdose as an emergency.
Is Cosequin safe for diabetic dogs?
There is a theoretical concern that glucosamine, an amino sugar, could influence glucose handling, but strong canine clinical evidence for this is lacking. Because the question is unresolved, discuss it with your veterinarian before starting, and follow whatever monitoring they advise.
How long before side effects appear, and how long until benefits do?
Reported reactions tend to appear within the first days. Benefit, where it occurs, is slower: in the McCarthy trial, significant improvements in pain and weight-bearing scores were recorded by day 70, with a slower onset than the carprofen comparison group. Other trials, including the 2023 Frontiers force-plate study, found no significant objective improvement over placebo at six weeks.
Can my dog take Cosequin with an NSAID like carprofen?
Many dogs are on both under veterinary supervision, but that combination should be your vet’s call, not a decision made at home — partly because a supplement reaction and an NSAID reaction can look identical.
My dog is allergic to shellfish. Can he still take it?
Possibly, but ask your vet. Shellfish allergy is generally a reaction to muscle protein rather than to the shell chitin that glucosamine is derived from, and the question has been examined in human allergy research without confirming the risk. Canine-specific evidence is limited.
The short version
Cosequin’s side effect profile is mild and mostly digestive, its efficacy evidence is genuinely mixed, and its one documented severe risk is an overdose scenario driven by manganese. Those three facts together should shape how you use it: with food, with the bottle stored safely, with realistic expectations measured in weeks rather than days, and with your veterinarian informed that your dog is taking it.
References
- McCarthy G, O’Donovan J, Jones B, McAllister H, Seed M, Mooney C. “Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis.” The Veterinary Journal, 2007;174(1):54–61. DOI: 10.1016/j.tvjl.2006.02.015. PMID: 16647870. pubmed.ncbi.nlm.nih.gov/16647870
- Kampa N, Kaenkangploo D, Jitpean S, et al. “Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial.” Frontiers in Veterinary Science, 2023;10:1033188. DOI: 10.3389/fvets.2023.1033188. PMID: 36816197. frontiersin.org
- Bhathal A, Spryszak M, Louizos C, Frankel G. “Glucosamine and chondroitin use in canines for osteoarthritis: A review.” Open Veterinary Journal, 2017;7(1):36–49. DOI: 10.4314/ovj.v7i1.6. PMID: 28331832. pubmed.ncbi.nlm.nih.gov/28331832
- Borchers A, Epstein SE, Gindiciosi B, Cartoceti A, Puschner B. “Acute enteral manganese intoxication with hepatic failure due to ingestion of a joint supplement overdose.” Journal of Veterinary Diagnostic Investigation (University of California–Davis), 2014;26(5):658–663. DOI: 10.1177/1040638714544316. PMID: 25080444. pubmed.ncbi.nlm.nih.gov/25080444
- Jaffey JA, Chamberlin T, Hu J. “Acute manganese toxicosis related to joint health supplement ingestion in two dogs.” Topics in Companion Animal Medicine, 2024;61:100877. DOI: 10.1016/j.tcam.2024.100877. PMID: 38788832. pubmed.ncbi.nlm.nih.gov/38788832
- ASPCA Pro. “Overdoses of Oral Chondroprotective Agents.” ASPCA Animal Poison Control Center. aspcapro.org
- American Regent, Inc. “Adequan Canine (polysulfated glycosaminoglycan) injection, solution” — FDA-approved product label, Contraindications section. DailyMed, National Library of Medicine (label version accessed September 2026). dailymed.nlm.nih.gov
- Gray HC, Hutcheson PS, Slavin RG. “Is glucosamine safe in patients with seafood allergy?” Journal of Allergy and Clinical Immunology, 2004;114(2):459–460. DOI: 10.1016/j.jaci.2004.05.050. PMID: 15341031. pubmed.ncbi.nlm.nih.gov/15341031
- Nutramax Laboratories. “Cosequin Joint Health Supplement for Dogs — Chewable Tablets with Glucosamine, Chondroitin, and MSM” (active ingredient panel, accessed September 2026). cosequin.com
Veterinary disclaimer: This article is for general information and is not veterinary advice. It does not diagnose, treat, prevent or cure any condition. No amount, frequency or duration mentioned here is an instruction — figures are reported from the cited sources or from a manufacturer’s published label. Always follow your product label and consult a licensed veterinarian before starting, changing or stopping any supplement, particularly if your dog is on medication, has an existing health condition, is pregnant or nursing, or is a puppy. If you suspect an overdose or an allergic reaction, seek emergency veterinary care immediately.
Dog Health Insider is an independent publication. Cosequin and Nutramax are trademarks of their respective owners; we are not affiliated with them.